BRAND NAME:
RXN

GENERIC NAME:
Rivaroxaban

THERAPEUTIC SEGMENT:
Cardiovascular 

INDICATIONS:
For the treatment of the following conditions:

• Reduction of risk of stroke and systemic embolism in non-valvular atrial fibrillation.
• Deep Vein Thrombosis (DVT)
• Pulmonary Embolism (PE)
• Reduction in the risk of recurrence of deep vein thrombosis and of pulmonary embolism following initial 6 months’ treatment for DVT and/or PE.
• Prophylaxis of deep vein thrombosis which may lead to PE in patients undergoing knee or hip replacement surgery.

BRIEF DESCRIPTION:
Rivaroxaban is an orally bioavailable factor Xa inhibitor that selectively blocks the active site of factor Xa and does not require a cofactor (such as Anti-thrombin III) for activity. Activation of factor X to factor Xa (FXa) via the intrinsic and extrinsic pathways plays a central role in the cascade of blood coagulation.

DOSAGE FORM:
Tablet 2.5 mg, 10mg

PACK SIZE:
10’s